title: Introduction of a second dose of measles in national immunization program in India: a major step towards eradication.
abstract: Measles is a highly infectious, acute respiratory illness that is caused by a virus of the genus Morbillivirus. The disease infects nearly 30 million children each year, and deaths usually occur from complications related to pneumonia, diarrhea and malnutrition. A systematic review of published Indian literature depicts the median case fatality ratio (CFR) of measles to be 1.6%. Through immunization, measles deaths dropped a remarkable 78% from 733,000 in 2000 to 164,000 in 2008. As of 2008, 192 of 193 Member States of WHO use 2 doses of measles vaccine in their national immunization programs, India being the only exception. The Millennium Development Goal (MDG) 4 aims to reduce by two-thirds between 1990 and 2015 the under-five mortality rate (U5MR) in the world. Per the draft comprehensive Multi Year Strategic Plan (cMYP, 2010–17) for immunization of India, the country aims to reduce measles-related mortality by 90% by 2013 when compared to 2000. As recommended by the National Technical Advisory Group on Immunization (NTAGI), the implementation strategy of the second dose of measles vaccine at the state level is determined by the underlying performance of the routine immunization program. The second dose in the national immunization schedule gives extra immunity against measles infection that renders children more susceptible to secondary pneumonia and diarrheal diseases, which are the primary causes of under-5 child mortality in India.
authors.affiliation: Department of Community Medicine, Pt. B.D. Sharma PGIMS, Rohtak, India. dr.rameshverma@yahoo.co.in
authors.forename: Ramesh
authors.initials: R
authors.lastname: Verma
authors.forename: Pardeep
authors.initials: P
authors.lastname: Khanna
authors.forename: Mohan
authors.initials: M
authors.lastname: Bairwa
authors.forename: Suraj
authors.initials: S
authors.lastname: Chawla
authors.forename: Shankar
authors.initials: S
authors.lastname: Prinja
authors.forename: Meena
authors.initials: M
authors.lastname: Rajput
mesh_terms: D002675:Child, Preschool; D006291:Health Policy; D006801:Humans; D017589:Immunization Programs; D007117:Immunization, Secondary / Q000379:methods*; D007194:India / Q000453:epidemiology; D007223:Infant; D008457:Measles / Q000453:epidemiology* / Q000517:prevention & control*; D008458:Measles Vaccine / Q000008:administration & dosage* / Q000276:immunology*; D014611:Vaccination / Q000379:methods*
chemical_list: D008458:Measles Vaccine